STOCK TITAN

TNL Mediagene Financials

TNMG
FY2025 annual
Revenue $35.8M -26.1% YoY
Net Income -$1.2M +98.6% YoY
EPS (Diluted) Not reported for FY2025
Free Cash Flow -$1.5M +85.3% YoY
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Apr 30, 2026 Reported Currency USD FYE April

TNL Mediagene (TNMG) reported $35.8M in revenue for fiscal year 2025, down 26.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TNMG FY2025

TNL Mediagene’s dominant mechanic is financing-supported growth: revenue expanded while operating cash conversion weakened and short-term liquidity tightened.

In FY2024, revenue increased by 35.4% while operating cash flow fell to -$10.2M, revealing that added sales required substantially more cash support rather than improving self-funding. Net loss reached -$85.0M while free cash flow was -$10.3M, so the accounting loss was far larger than the cash outflow, consistent with non-cash items or working-capital effects driving much of the reported deterioration.

Working-capital pressure is more immediate than conventional debt pressure: current liabilities exceeded current assets by $15.3M in FY2024, producing a 0.5x current ratio and indicating that near-term obligations were not matched by listed current resources. Total liabilities were $56.5M against $36.4M of equity, adding balance-sheet obligations beyond the short-term gap.

Operating cash flow of -$10.2M was nearly offset by $10.0M in financing inflows, showing FY2024 cash movement depended on funding rather than operations. The reported liquidity comparison was 30.7 months, which describes period-end cash and investments relative to one year of reported outflow, not operating self-sufficiency.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 43 / 100
Financial Health Score 43/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of TNL Mediagene's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
56
Dilution
99
R&D Intensity
0

Not available for TNL Mediagene, and counted as zero in the overall score.

Revenue Progress
48
Burn Trend
42
Balance Sheet
12
Piotroski F-Score Partial
2/8

TNL Mediagene passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

TNL Mediagene reported a net loss of $1.2M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$35.8M
YoY-26.1%

TNL Mediagene generated $35.8M in revenue in fiscal year 2025. This represents a decrease of 26.1% from the prior year.

Net Income
-$1.2M
YoY+98.6%

TNL Mediagene reported -$1.2M in net income in fiscal year 2025. This represents an increase of 98.6% from the prior year.

EBITDA

Not reported for fiscal year 2025.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$1.5M
YoY+85.3%

TNL Mediagene recorded an outflow of $1.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 85.3% from the prior year.

Cash & Debt
$3.6M
YoY0.0%

TNL Mediagene held $3.6M in cash against $4.1M in long-term debt as of fiscal year 2025.

Shares Outstanding
3M

TNL Mediagene had 3M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Net Margin
-3.4%

TNL Mediagene's net profit margin was -3.4% in fiscal year 2025, showing the share of revenue converted to profit. No change is given against fiscal year 2024: its reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity
-3.3%
YoY+230.1pp

TNL Mediagene's ROE was -3.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 230.1 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Capital Allocation

Capital Expenditures
$87K
YoY-2.2%

TNL Mediagene invested $87K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 2.2% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

Share Buybacks

Not reported for fiscal year 2025.

TNMG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TNMG quarterly income statement
MetricQ3'25Q3'24

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, Interest Expense, Income Tax, Net Income, EPS (Diluted).

TNMG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TNMG quarterly balance sheet
MetricQ3'25Q3'24
Total Assets$92.9M-22.3%$119.6M
Current Assets$17.7M+5.2%$16.9M
Cash & Equivalents$3.6M+20.3%$3.0M
Inventory$88K-24.0%$116K
Accounts Receivable$8.2M-6.9%$8.8M
Goodwill$34.0M-44.1%$60.7M
Total Liabilities$56.5M+19.6%$47.2M
Current Liabilities$33.0M+32.5%$24.9M
Long-Term Debt$4.1M-18.0%$5.0M
Total Equity$36.4M-49.7%$72.4M
Retained Earnings-$117.2M-264.0%-$32.2M

TNMG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TNMG quarterly cash flow statement
MetricQ3'25Q3'24

Not reported in any period shown, so not listed: Operating Cash Flow, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

TNMG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TNMG quarterly financial ratios
MetricQ3'25Q3'24
Current Ratio0.54-0.1x0.68
Debt-to-Equity0.110.0x0.07

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, FCF Margin.

Note: The current ratio is below 1.0 (0.54), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is TNL Mediagene's annual revenue?

TNL Mediagene (TNMG) reported $35.8M in total revenue for fiscal year 2025. This represents a -26.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is TNL Mediagene's revenue growing?

TNL Mediagene (TNMG) revenue declined by 26.1% year-over-year, from $48.5M to $35.8M in fiscal year 2025.

Is TNL Mediagene profitable?

No, TNL Mediagene (TNMG) reported a net income of -$1.2M in fiscal year 2025, with a net profit margin of -3.4%.

As of fiscal year 2025, TNL Mediagene (TNMG) had $3.6M in cash and equivalents against $4.1M in long-term debt.

TNL Mediagene (TNMG) had a net profit margin of -3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

TNL Mediagene (TNMG) has a return on equity of -3.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

TNL Mediagene (TNMG) recorded an outflow of $1.5M in free cash flow during fiscal year 2025. This represents a 85.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

TNL Mediagene (TNMG) recorded an outflow of $1.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

TNL Mediagene (TNMG) had $92.9M in total assets as of fiscal year 2025, including both current and long-term assets.

TNL Mediagene (TNMG) invested $87K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

TNL Mediagene (TNMG) had 3M shares outstanding as of fiscal year 2025.

TNL Mediagene (TNMG) had a current ratio of 0.54 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

TNL Mediagene (TNMG) had a debt-to-equity ratio of 0.11 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

TNL Mediagene (TNMG) had a return on assets of -1.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, TNL Mediagene (TNMG) held $3.6M in cash, cash equivalents and investments, and reported an operating cash outflow of $1.4M over that year. Dividing the one by the other, the reported balance equals about 31 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

TNL Mediagene (TNMG) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

TNL Mediagene (TNMG) reported a net loss of $1.2M while operations used $1.4M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

TNL Mediagene (TNMG) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top